Related Experiment Video
Updated: Aug 6, 2026

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
TPI1 Loss Triggers a Metabolite-Driven Mitochondrial Redox Vulnerability via the SARM1-cADPR-Ca2+ Axis
Chunyu Liu1,2, Shun Wu1,2, Chuang Wang1,2
1Senior Department of Urology, Chinese PLA General Hospital, Beijing, China.
Abstract:
Cellular senescence is a stable cell cycle arrest program with important therapeutic implications in cancer, yet how metabolic perturbations are translated into redox-dependent senescence remains incompletely understood. Here, we identify triosephosphate isomerase 1 (TPI1) as a critical regulator of senescence in clear cell renal cell carcinoma (ccRCC) through a customized CRISPR-Cas9 metabolic screen. TPI1 depletion induces a robust senescence phenotype characterized by mitochondrial redox imbalance, DNA damage, and stable growth arrest. Mechanistically, loss of TPI1 leads to accumulation of dihydroxyacetone phosphate (DHAP), which engages a SARM1-dependent signaling pathway, resulting in increased cyclic ADP-ribose (cADPR) production and intracellular Ca2+ release. This cADPR-Ca2+ axis drives mitochondrial ROS (mtROS) generation, thereby promoting DNA damage and activation of the p53-p21 pathway to enforce senescence. Pharmacological or genetic attenuation of calcium signaling, or mitochondrial ROS partially rescues these phenotypes, indicating that calcium-dependent redox stress is required for senescence induction. Importantly, this metabolic-redox signaling cascade is conserved across multiple cancer types. Collectively, our findings define a previously unrecognized TPI1-SARM1-cADPR-Ca2+ axis that links glycolytic metabolite accumulation to mitochondrial redox stress and cellular senescence, highlighting a metabolite-driven redox vulnerability that may be therapeutically exploitable in cancer.
Insights
Triosephosphate isomerase 1 (TPI1) depletion triggers cancer cell senescence by linking glycolytic metabolite buildup to mitochondrial redox stress. This TPI1-SARM1-cADPR-Ca2+ axis reveals a metabolic vulnerability for cancer therapy.
Area of Science:
- Metabolic regulation of cellular processes
- Cancer biology and redox signaling
- Cellular senescence mechanisms
Background:
- Cellular senescence is a key anti-cancer mechanism, but the metabolic drivers of senescence remain unclear.
- Understanding how metabolic changes induce redox-dependent senescence is crucial for cancer therapeutics.
- Triosephosphate isomerase 1 (TPI1) role in senescence is not well-defined.
Purpose of the Study:
- To identify metabolic regulators of senescence in clear cell renal cell carcinoma (ccRCC).
- To elucidate the molecular mechanisms linking metabolic perturbations to redox-dependent senescence.
- To explore the therapeutic potential of targeting the identified metabolic-redox axis in cancer.
Main Methods:
- CRISPR-Cas9 metabolic screening to identify senescence regulators.
- Analysis of TPI1 depletion effects on cell cycle arrest, mitochondrial function, and DNA damage.
- Investigation of the SARM1-cADPR-Ca2+-mtROS signaling pathway.
- Pharmacological and genetic inhibition of calcium signaling and mitochondrial ROS.
Main Results:
- TPI1 depletion induces senescence characterized by mitochondrial redox imbalance, DNA damage, and growth arrest.
- Loss of TPI1 leads to dihydroxyacetone phosphate (DHAP) accumulation, activating SARM1-dependent signaling.
- The TPI1-SARM1-cADPR-Ca2+-mtROS axis drives senescence via p53-p21 activation.
- Inhibition of calcium signaling or mtROS partially rescues senescence phenotypes.
Conclusions:
- A novel TPI1-SARM1-cADPR-Ca2+ axis links glycolytic metabolite accumulation to mitochondrial redox stress and senescence.
- Metabolite-driven redox stress represents a vulnerability exploitable in cancer therapy.
- This metabolic-redox signaling cascade is conserved across multiple cancer types.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
PI3K/mTOR/AKT Signaling Pathway
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Regulation of the Unfolded Protein Response
Mitochondrial Membranes
mTOR Signaling and Cancer Progression
The mTOR pathway or the...